China Approves Three More COVID-19 Vaccines in First-Half 2021

BEIJING--July 13, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--China's National Medical Products Administration (NMPA) has approved 20 patterned drugs/vaccines since the beginning of the year, including three COVID-19 vaccines from SINOPharm, SINOVac and CanSinoBIO, according to a statement from the NMPA.